567 related articles for article (PubMed ID: 22527106)
81. Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
Henry NL; Speth K; Lintermans A; Kidwell KM; Carlson R; Hayes DF; Neven P
Clin Breast Cancer; 2017 Aug; 17(5):350-355.e4. PubMed ID: 28365336
[TBL] [Abstract][Full Text] [Related]
82. Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment--the COMPAS study.
Ziller V; Kyvernitakis I; Knöll D; Storch A; Hars O; Hadji P
BMC Cancer; 2013 Sep; 13():407. PubMed ID: 24006873
[TBL] [Abstract][Full Text] [Related]
83. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL).
Hershman DL; Kushi LH; Hillyer GC; Coromilas E; Buono D; Lamerato L; Bovbjerg DH; Mandelblatt JS; Tsai WY; Zhong X; Jacobson JS; Wright JD; Neugut AI
Breast Cancer Res Treat; 2016 May; 157(1):133-43. PubMed ID: 27086286
[TBL] [Abstract][Full Text] [Related]
84. Obesity and nonadherence correlate with elevated serum estradiol levels in postmenopausal women receiving adjuvant aromatase inhibitor therapy.
Decker DA; Reynolds RB; Molthrop DC; Griffith E; Encarnacion T; Lee E; Zhu X
Breast J; 2014; 20(5):553-4. PubMed ID: 25088121
[No Abstract] [Full Text] [Related]
85. Treatment sequence of aromatase inhibitors and radiotherapy and long-term outcomes of breast cancer patients.
Ishitobi M; Shiba M; Nakayama T; Motomura K; Koyama H; Nishiyama K; Tamaki Y
Anticancer Res; 2014 Aug; 34(8):4311-4. PubMed ID: 25075064
[TBL] [Abstract][Full Text] [Related]
86. Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer.
Brockway JP; Shapiro CL
Oncology (Williston Park); 2018 May; 32(5):235-7, 249. PubMed ID: 29847854
[TBL] [Abstract][Full Text] [Related]
87. A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
Martínez N; Herrera M; Frías L; Provencio M; Pérez-Carrión R; Díaz V; Morse M; Crespo MC
Clin Transl Oncol; 2019 Apr; 21(4):489-498. PubMed ID: 30293230
[TBL] [Abstract][Full Text] [Related]
88. Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: A randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
Tan EH; Wong ALA; Tan CC; Wong P; Tan SH; Ang LEY; Lim SE; Chong WQ; Ho J; Lee SC; Tai BC
Breast; 2020 Oct; 53():77-84. PubMed ID: 32652462
[TBL] [Abstract][Full Text] [Related]
89. Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry.
Stanton AL; Petrie KJ; Partridge AH
Breast Cancer Res Treat; 2014 Jun; 145(2):525-34. PubMed ID: 24781972
[TBL] [Abstract][Full Text] [Related]
90. Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer.
Joyce E; Tao X; Stearns V; Hayes DF; Storniolo AM; Kidwell KM; Henry NL
Breast Cancer Res Treat; 2024 Apr; 204(3):539-546. PubMed ID: 38198070
[TBL] [Abstract][Full Text] [Related]
91. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
[TBL] [Abstract][Full Text] [Related]
92. Adherence to Adjuvant Aromatase Inhibitor Therapy Among Postmenopausal Hispanic/Latino Women With Breast Cancer.
Philipovskiy A; Campbell A; Heydarian R; Castillo B; Dwivedi AK; McCallum R; Aguilera R; Gaur S; Nahleh Z
Anticancer Res; 2020 Feb; 40(2):857-864. PubMed ID: 32014929
[TBL] [Abstract][Full Text] [Related]
93. What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy.
Heisig SR; Shedden-Mora MC; von Blanckenburg P; Rief W; Witzel I; Albert US; Nestoriuc Y
Psychooncology; 2016 Dec; 25(12):1485-1492. PubMed ID: 26913587
[TBL] [Abstract][Full Text] [Related]
94. Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer.
Friese CR; Pini TM; Li Y; Abrahamse PH; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Hawley ST; Katz SJ; Griggs JJ
Breast Cancer Res Treat; 2013 Apr; 138(3):931-9. PubMed ID: 23542957
[TBL] [Abstract][Full Text] [Related]
95. Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105.
Hershman DL; Unger JM; Hillyer GC; Moseley A; Arnold KB; Dakhil SR; Esparaz BT; Kuan MC; Graham ML; Lackowski DM; Edenfield WJ; Dayao ZR; Henry NL; Gralow JR; Ramsey SD; Neugut AI
J Clin Oncol; 2020 Jul; 38(19):2122-2129. PubMed ID: 32369401
[TBL] [Abstract][Full Text] [Related]
96. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL).
Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Buono DL; Nathanson SD; Bovbjerg DH; Mandelblatt JS; Tsai WY; Jacobson JS; Hershman DL
Breast Cancer Res Treat; 2016 Jul; 158(1):127-138. PubMed ID: 27287779
[TBL] [Abstract][Full Text] [Related]
97. A prospective study of aromatase inhibitor therapy initiation and self-reported side effects.
Gallicchio L; Calhoun C; Helzlsouer K
Support Care Cancer; 2017 Sep; 25(9):2697-2705. PubMed ID: 28341972
[TBL] [Abstract][Full Text] [Related]
98. Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors.
Thompson PA; Huang C; Yang J; Wertheim BC; Roe D; Zhang X; Ding J; Chalasani P; Preece C; Martinez J; Chow HS; Stopeck AT
Clin Cancer Res; 2021 Oct; 27(20):5660-5668. PubMed ID: 34112707
[TBL] [Abstract][Full Text] [Related]
99. Relationship between physical activity practice and metabolic profile of postmenopausal women under treatment with aromatase inhibitors for breast cancer.
de Paulo TRS; Viezel J; Aro BL; Seidinger SC; Trindade ACAC; Christofaro DGD; Freitas IF
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():33-37. PubMed ID: 28700959
[TBL] [Abstract][Full Text] [Related]
100. Adjuvant chemotherapy for breast cancer patients: patients' expectations and physicians' attitudes.
Barak F; Ostrowsky LA; Kreitler S
Palliat Support Care; 2012 Jun; 10(2):107-14. PubMed ID: 22361448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
